Data as of 05:57 AM on Nov 3rd, 2026
value
Data as of 06:08 AM on Nov 3rd, 2026
| Vaccine | Immunizations |
|---|---|
| Td vaccine | 176.67K |
| DTaP-HepB-IPV-Hib vaccine | 117.22K |
| 15-valent pneumococcal conjugate vaccine | 111.47K |
| Measles, Mumps, and Rubella (MMR) combined vaccine | 100.39K |
| Tuberculosis vaccine | 58.75K |
| Rotavirus vaccine | 56.67K |
| DTaP-IPV vaccine | 50.72K |
| TDaP vaccine | 49.25K |
| Purified Protein Derivative (PPD) | 49.09K |
| Human papillomavirus (HPV) vaccine | 40.32K |
| Hepatitis B vaccine | 39.64K |
| DTaP-IPV-Hib vaccine | 38.16K |
| Varicella (chickenpox) vaccine | 28.08K |
| Seasonal influenza vaccine | 27.78K |
| Other | 24.11K |
| Nasal seasonal influenza vaccine | 19.21K |
| Tetanus vaccine | 17.87K |
| Rabies vaccine | 7.42K |
| 20-valent pneumococcal conjugate vaccine | 5.74K |
| 10-valent pneumococcal conjugate vaccine | 5.08K |
| COVID-19 vaccine | 3.57K |
| 13-valent pneumococcal conjugate vaccine | 1.98K |
| Combined Hepatitis A and B vaccine | 1.87K |
| Meningococcal vaccine (В) | 1.68K |
| Yellow fever vaccine | 1.40K |
| Meningococcal vaccine (A, C, W135, Y) | 1.10K |
| RSV vaccine (Respiratory Syncytial Virus vaccine) | 880 |
| Hepatitis A vaccine | 168 |
| Antitetanus serum | 140 |
| CCHF vaccine (Crimean-Congo Hemorrhagic Fever vaccine) | 88 |
Data as of 05:50 AM on Nov 3rd, 2026